2,2,2-三氟-N-(咪唑并[1,2-A]吡啶-2-基)乙酰胺 | 504413-26-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 咪唑并吡啶类
• 中文名称: 2,2,2-三氟-N-(咪唑并[1,2-A]吡啶-2-基)乙酰胺
• 英文名称: trifluoro-N-imidazo[1,2-a]pyridin-2-ylacetamide
• 英文别名: 2,2,2-trifluoro-N-(imidazo[1,2-a]pyridin-2-yl)acetamide；2,2,2-trifluoro-N-imidazo[1,2-a]pyridin-2-ylacetamide
• CAS: 504413-26-7
• 化学式: C₉H₆F₃N₃O
• 分子量: 229.161
• InChiKey: UUNDTHNXCSUIRY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  16
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.11
• 拓扑面积：
  46.4
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  2,2,2-三氟-N-(咪唑并[1,2-A]吡啶-2-基)乙酰胺 在 水 、 sodium hydroxide 作用下， 以 四氢呋喃 为溶剂， 反应 2.0h， 生成 咪唑并[1,2-a]吡啶-2-胺
  参考文献：
  名称：

  2-氨基咪唑并[1,2- a ]吡啶的选择性C-酰化反应：在咪唑并吡啶[1,3]二氮杂吡啶酮类化合物的合成中的应用

  摘要：

  一系列20个光学纯的3,4-二氢-5 H-吡啶并[1'，2'：1,2]咪唑并[4,5- d ] [1,3]二氮杂-5-酮形成一个新家族分四步合成了氮杂杂环融合的[1,3]二氮杂ze，总产率为17-66％。关键步骤包括在C-3处容易获得的2-氨基咪唑并[1,2- a ]吡啶的选择性C-酰化反应。

  DOI：

  10.1021/jo300364d
• 作为产物：
  描述：

  N-(2-pyridyl)-p-toluenesulfonamide 在 N,N-二异丙基乙胺 作用下， 以 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 反应 28.0h， 生成 2,2,2-三氟-N-(咪唑并[1,2-A]吡啶-2-基)乙酰胺
  参考文献：
  名称：

  2-氨基咪唑并[1,2- a ]吡啶的选择性C-酰化反应：在咪唑并吡啶[1,3]二氮杂吡啶酮类化合物的合成中的应用

  摘要：

  一系列20个光学纯的3,4-二氢-5 H-吡啶并[1'，2'：1,2]咪唑并[4,5- d ] [1,3]二氮杂-5-酮形成一个新家族分四步合成了氮杂杂环融合的[1,3]二氮杂ze，总产率为17-66％。关键步骤包括在C-3处容易获得的2-氨基咪唑并[1,2- a ]吡啶的选择性C-酰化反应。

  DOI：

  10.1021/jo300364d

文献信息

• [EN] TRPC5 INHIBITORS AND METHODS OF USING SAME<br/>[FR] INHIBITEURS DE TRPC5 ET LEURS PROCÉDÉS D'UTILISATION
  申请人：UNIV NEBRASKA

  公开号：WO2019051197A1

  公开（公告）日：2019-03-14

  Provided herein are TRPC5 inhibitors and methods of using the same, e.g., to protect podocytes and/or treat kidney disease.

  本文提供了TRPC5抑制剂及其使用方法，例如用于保护足细胞和/或治疗肾脏疾病。
• TRPC5 inhibitors and methods of using same
  申请人：BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA

  公开号：US11370769B2

  公开（公告）日：2022-06-28

  Provided herein are TRPC5 inhibitors and methods of using the same, e.g., to protect podocytes and/or treat kidney disease.

  本文提供了TRPC5抑制剂及其使用方法，例如保护荚膜细胞和/或治疗肾病的方法。
• Pyrido-imidazodiazepinones as a new class of reversible inhibitors of human kallikrein 7
  作者：Dominique P. Arama、Feryel Soualmia、Vincent Lisowski、Jean-François Longevial、Elodie Bosc、Ludovic T. Maillard、Jean Martinez、Nicolas Masurier、Chahrazade El Amri

  DOI：10.1016/j.ejmech.2015.02.008

  日期：2015.3

  The human tissue kallikrein-7 (KLK7) is a chymotryptic serine protease member of tissue kallikrein family. KLK7 is involved in skin homeostasis and inflammation. Excess of KLK7 activity is also associated with tumor metastasis processes, especially in ovarian carcinomas, prostatic and pancreatic cancers. Development of Kallikrein 7 inhibitors is thus of great interest in oncology but also for treating skin diseases. Most of the developed synthetic inhibitors present several drawbacks such as poor selectivity and unsuitable physico-chemical properties for in vivo use. Recently, we described a practical sequence for the synthesis of imidazopyridine-fused [1,3]-diazepines. Here, we report the identification of pyrido-imidazodiazepinone core as a new potential scaffold to develop selective and competitive inhibitors of kallikrein-related peptidase 7. Structure-activity relationships (SAR), inhibition mechanisms and selectivity as well as cytotoxicity against selected cancer cell lines were investigated. (C) 2015 Elsevier Masson SAS. All rights reserved.
• An efficient synthesis of pyrido-imidazodiazepinediones
  作者：Dominique P. Arama、Vincent Lisowski、Eliana Scarlata、Pierre Fulcrand、Ludovic T. Maillard、Jean Martinez、Nicolas Masurier

  DOI：10.1016/j.tetlet.2012.12.087

  日期：2013.3

  We herein report the synthesis of a series of 12 optically pure 3,4-dihydro-1H-pyrido-[1',2':1,21-imidazo[4,5-d][1,31diazepine-2,5-diones, which form a new family of azaheterocycle-fused [1,3]diazepines. The key step of the synthesis consists in a selective C-acylation of 2-amino-imidazo[1,2-a]pyridine by various natural amino-acids, followed by an intracarbonylation reaction. (C) 2012 Elsevier Ltd. All rights reserved.
• Imidazopyridine-fused [1,3]-diazepinones: Synthesis and antiproliferative activity
  作者：Audrey Gallud、Ophélie Vaillant、Ludovic T. Maillard、Dominique P. Arama、Joëlle Dubois、Marie Maynadier、Vincent Lisowski、Marcel Garcia、Jean Martinez、Nicolas Masurier

  DOI：10.1016/j.ejmech.2014.01.044

  日期：2014.3

  A series of 15 pyrido-imidazo-1,3-diazepin-5-ones and pyrido-1,3-diazepine-2,5-diones were synthesized and their anticancer activities were evaluated. Among tested compounds on a cell lines panel, compound 6a presents the best growth inhibition activity on 21 cell lines with a cytotoxic effect on MDA-MB-435 melanoma cells. This compound led to deep cell morphological changes and revealed to be an inhibitor of the Hepatocyte progenitor kinase-like kinase (HGK), which is known to be implicated in the migration, adhesion and invasion of various tumor cells. (C) 2014 Elsevier Masson SAS. All rights reserved.